47
Views
21
CrossRef citations to date
0
Altmetric
Research Article

THE PROTECTIVE IMMUNE RESPONSE AGAINST VAGINAL CANDIDIASIS: LESSONS LEARNED FROM CLINICAL STUDIES AND ANIMAL MODELS

Pages 515-548 | Published online: 03 Aug 2009

  • J.D. Sobel, Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann. N.Y. Acad. Sci., 544: 547-557, 1988.
  • J.D. Sobel, Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin. Infect. Dis., 14: S148-S153, 1992.
  • H.L. Kent, Epidemiology of vaginitis. Am. J. Obstet. Gynecol., 165: 1168-1175, 1991.
  • F.C. Odds, Chronic mucocutaneous candidiosis. In Candida and Candidiasis, Baltimore, MD: University Park Press, p. 104, 1988.
  • M.E. Lynch, J.D. Sobel, and P.L. Fidel, Jr., Role of antifingal drug resistance in the pathogenesis of recurrent vulvovaginal candidasis. J. Med. Vet. Mycol. 34: 337-339, 1996.
  • J.F. Ryley and S. McGregor, Quantitation of vaginal Candida albicans infections in rodents. J. Med. Vet. Mycol, 24: 455-460, 1986.
  • P.L. Fidel, Jr., M.E. Lynch, and J.D. Sobel, Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect. Immun., 61: 1990-1995, 1993.
  • A. Valentin, C. Bernard, M. Mallie, M. Huerre, and J.M. Bastide, Control of Candida albicans vaginitis in mice by short-duration butoconazole treatment in situ. Mycoses, 36: 379-384, 1993.
  • O.S. Kinsman and A.E. Collard, Hormonal factors in vaginal candidiasis in rats. Infect. Immun., 53: 498-504, 1986.
  • P.L. Fidel, Jr., J.L. Cutright, and C. Steele, Effects of reproductive hormones on experimental vaginal candidiasis. Infect. Immun., 68: 651-657, 2000.
  • P.L. Fidel, Jr., M.E. Lynch, and J.D. Sobel, Candida-specific Th1-type respon- siveness in mice with experimental vaginal candidiasis. Infect. Immun., 61: 4202-4207, 1993.
  • S. Mathur, R.S. Mathur, J.M. Goust, H.O. Williamson, and H.H. Fundenberg, Cyclic variations in white cell subpopulations in the human menstrual cycle: Correlations with progesterone and estradiol. Clin. Immunol. Immunopathol., 13: 246-253, 1979.
  • M. Klink, B. Rozalaska, and W. Rudnicka, Weakness of cellular response to Listeria antigens in pregnant mice [Polish]. Medycyna Doswiadczalna i Mikrobiologia, 45(1): 51-54, 1993.
  • D.N. Mazumder, N. Ghose, J. Mirta, G. Dutta, and A. Santra, Immunological status of women with prolonged oral contraceptives and occurrence of giardiasis. Journal of the Indian Medical Association, 88(5): 129-131, 1990.
  • A. Cassone, M. Boccanera, D.A. Adriani, G. Santoni, and F. De Bernardis, Rats clearing a vaginal infection by Candida albicans aquire specific, antibody-mediated resistance to vaginal infection. Infect. Immun., 63: 2619-2624, 1995.
  • P.L. Fidel, Jr., M.E. Lynch, V. Redondo-Lopez, J.D. Sobel, and R. Robinson, Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis (RWC). J. Infect. Dis., 168: 1458-1465, 1993.
  • P.L. Fidel, Jr., M.E. Lynch, and J.D. Sobel, Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis. Infect. Immun., 62: 1032-1038, 1994.
  • P.L. Fidel, Jr., M.E. Lynch, D.H. Conaway, L. Tait, and J.D. Sobel, Mice immunized by primary vaginal C. albicans infection develop acquired vaginal mucosal immunity. Infect. Immune., 63: 547-553, 1995.
  • P. L. Fidel, Jr., J.L. Cutright, and J.D. Sobel, Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infections. Infect. Immun., 63: 4191-4194, 1995.
  • P. L. Fidel, Jr., M.E. Lynch, and J.D. Sobel, Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect. Immun., 63: 2403-2408, 1995.
  • P.L. Fidel, Jr., N.A. Wolf, and M.A. KuKuruga, T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery. Infect. Immun., 64: 3793-3799, 1996.
  • L. Polonelli, F. De Bernardis, S. Conti, M. Boccanera, M. Gerloni, G. Morace, W. Magliani, C. Chezzi, and A. Cassone, Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies. J. Immunol., 152: 3175-3182, 1994.
  • L. Polonelli, F. De Bernardis, S. Conti, M. Boccanera, W. Magliani, M. Gerloni, C. Cantella, and A. Cassone, Human natural yeast killer toxin-like candidicidal antibodies. J. Immunol., 156: 1880-1885, 1996.
  • F. De Bernardis, M. Boccanera, D. Adriana, E. Spreghini, G. Santoni, and A. Cassone, Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect. Immun., 65: 3399-3405, 1997.
  • C. Steele, M. Ratteree, and P.L. Fidel, Jr., Differential susceptibility to experimental vaginal candidiasis in macaques. J. Infect. Dis., 180: 802-810, 1999.
  • D.V. Ehrensaft, R.B. Epstien, S. Sarpel, and B.R. Andersen, Disseminated candidias in leukopenic dogs. Proc. Soc. Exp. Biol. Med., 160: 6-10, 1979.
  • H. W. Holm and R.M. Marwin, Effects of surface active agents on the susceptibility of Swiss mice to Candida albicans. Mycopathol. Mycol. Appl., 33: 186-192, 1967.
  • E. Brummer, J.G. McEwen, and D.A. Stevens, Fungicidal activity of murine inflammatory polymorphonuclear neutrophils: Comparison with murine peripheral blood PMN. Clin. Exp. Immunol., 66: 681-690, 1986.
  • C.J. Morrison, E. Brummer, and D.A. Stevens, Effect of a local immune reaction on peripheral blood polymorphonuclear neutrophil microbicidal function: Studies with fungal targets. Cell Immunol., 110: 176-182, 1987.
  • M. Baccarini, F. Bistoni, P. Puccetti, and E. Garaci, Natural cell-mediated cytotoxicity against Candida albicans induced by cyclophosphamide: Nature of the in vitro cytotoxic effector. Infect. Immun., 42: 1-9, 1983.
  • J.Y. Djeu and D.K. Blanchard, Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor. J. Immunol., 139: 2761-2767, 1987.
  • L. Romani, S. Mocci, C. Bietta, L. Lanfaloni, P. Puccetti, and F. Bistoni, Th1 and Th2 cytokine secretion patterns in murine candidiasis: Association of Th1 responses with acquired resistance. Infect. Immun., 59: 4647-4654, 1991.
  • L. Romani, A. Mencacci, E. Cenci, R. Spaccapelo, P. Mosci, P. Puccetti, and F. Bistoni, CD + subset expression in murine candidiasis. J. Immunol., 150: 925-931, 1993.
  • L. Romani, P. Puccetti, and F. Bistoni, Biological role of Th cell subsets in candidiasis. In S. Romagnani, (Ed.), Th1 and Th2 Cells in Health and Disease, Farmington, CT: Karger, p. 114, 1996.
  • R.S. Klein, C.A. Harris, C.B. Small, B. Moll, M. Lesser, and G.H. Friedland, Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med., 311: 354-357, 1984.
  • A.M. Macher, The pathology of AIDS. Public Health Report, 103: 246-254, 1988.
  • R.A. Clift, Candidiasis in the transplant patient. Amer. J. Med., 77(Suppl.4D): 34-38, 1984.
  • L. Knight and J. Fletcher, Growth of Candida albicans in saliva: Stimulation by glucose associated with antibiotics, corticosteriods and diabetes mellitus. J. Infect. Dis., 123: 371-377, 1971.
  • C.H. Kirkpatrick, Chronic mucocutaneous candidiasis. Eur. J. Clin. Microbiol. Infect. Dis., 8: 448-456, 1989.
  • C.H. Kirkpatrick, R.R. Rich, and J.E. Bennett, Chronic mucocutaneous candidiasis: Model building in cellular immunity. Ann. Intern. Med., 75: 955-978, 1971.
  • R.Y. Paterson, R. Semo, G. Blumenschein, and J. Swelstad, Mucocutaneous candidiasis, energy and a plasma inhibitor of cellular immunity: Reversal after amphotericin B therapy. Clin. Exp. Immunol., 9: 595-602, 1971.
  • M.T. Cantorna and E. Balish, Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect. Immun., 58: 1093-1100, 1990.
  • E. Balish, H. Filutowicz, and T.D. Oberley, Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice. Infect. Immun., 58: 107-113, 1990.
  • E. Cenci, A. Mencacci, R. Spaccapelo, L. Tonnetti, P. Mosci, K.H. Enssle, P. Puc- cetti, L. Romani, and F. Bistoni, T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J. Infect. Dis., 171: 1279-1288, 1995.
  • T.J. Rogers and E. Balish, Immunity to Candida albicans. Microbiological Rev., 44: 660-682, 1980.
  • A. Ferrante and Y.H. Thong, Requirement of heat-labile opsonins for maximal phagocytosis of Candida albicans. Sabouraudia., 17: 293-297, 1979.
  • K. Kagaya and Y. Fukazawa, Murine defense mechanism against Candida albicans infection. II. Opsonization, phagocytosis and intracellular killing of Candida albicans. Microbiol. Immunol., 25: 807-818, 1981.
  • M. Yamamura and H. Valdimarsson, Participation of C3 in intracellular of Candida albicans. Scand. J. Immunol. 6: 591-594, 1977.
  • S. Mathur, G. Virella, J. Koistinen, E.O. Horger, TA. Mahvi, and H.H. Fudenberg, Humoral immunity in vaginal candidiasis. Infect. Immun., 15: 287-294, 1977.
  • W.F. Liljemark and R.J. Gibbons, Suppression of Candida albicans by human oral streptococci in gnotobiotic mice. Infect. Immun., 8: 846-849, 1973.
  • R.C. Matthews, J.P. Burnie, and S. Tabaqchali, Immunoblot analysis of the sero- logical response in systemic candidosis. Lancet, 2: 1415-1418, 1984.
  • S.H. E. Kaufmann, Heat shock proteins and the immune response. Immunol. Today, 11(4): 129-136, 1990.
  • Y. Han and J.E. Cutler, Antibody response that protects against disseminated candidiasis. Infect. Immun., 63: 2714-2719, 1995.
  • R.C. Matthews, J.P. Burnie, D. Howat, T. Rowland, and F. Walton, Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology, 74: 20-24, 1991.
  • A. Casadevall, Antibody immunity and invasive fungal infections. Infect. Immun., 63: 4211-4218, 1995.
  • R.F. Hector, J.E. Domer, and E.W. Carrow, Immune responses to Candida albicans in genetically distinct mice. Infect. Immun., 38: 1020-1028, 1982.
  • R.L. Fidel, Jr., W. Luo, J. Chabain, N.A. Wolf, and E. Van Buren, Use of cellular depletion analysis to examine circulation of immune effector function between the vagina and the periphery. Infect. Immun., 65: 3939-3943, 1997.
  • C.A. Black, F.M. Eyers, A. Russell, M.L. Dunkley, R.L. Clancy, and K.W. Beagley, Increased severity of Candida vaginitis in BALB/c nu/nu mice versus the parent strain is not abrogated by adoptive transfer of T cell enriched lymphocytes. J. Reprod. Immunol., 45: 1-18, 1999.
  • R.D. Mulero-Marchese, K.J. Blank, and T.G. Sieck, Genetic basis for protection against experimental vaginal candidiasis by peripheral immunization. J. Infect. Dis., 178: 227-234, 1998.
  • R.D. Mulero-Marchese, K.J. Blank, and T.G. Sieck, Strain-dependent migration of lymphocytes to the vaginal mucosa after peripheral immunization. Immuno- genetics, 49: 973-980, 1999.
  • S.S. Witkin, Inhibition of Conrfirfo-induced lymphocyte proliferation by antibody to Candida albicans. Obstet. Gynecol., 68: 696-699, 1986.
  • S.S. Witkin, J. Hirsch, and W.J. Ledger, A macrophage defect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am. J. Obstet. Gynecol., 155: 790-795, 1986.
  • J.R. Hobbs, D. Briden, F. Davidson, M. Kahan, and J.K. Oates, Immunological aspects of candidal vaginitis. Proc. R. Soc. Med., 70: 11-14, 1977.
  • I.W. Fong, P. McCleary, and S. Read, Cellular immunity of patients with recurrent or refractory vulvovaginal moniliasis. Am. J. Obstet. Gynecol., 166: 887-890, 1992.
  • R.A. Syverson, H. Buckley, J. Gibian, and J.J. M. Ryan, Cellular and humoral immune status in women with chronic Candida vaginitis. Am. J. Obstet. Gynecol., 134: 624-627, 1979.
  • W. Mendling and U. Koldovsky, Investigations by cell-mediated immunologic tests and therapeutic trials with thymopentin in vaginal mycoses. Infect. Dis. Obstet. Gynecol., 4, 225-231, 1996.
  • E.M. Corrigan, R.L. Clancy, M.L. Dunkley, F.M. Eyers, and K.W. Beagley, Cellular immunity in recurrent vulvovaginal candidiasis. Clin. Exp. Immunol., 111: 574-578, 1998.
  • D.N. Burns, R. Tuomala, B.H. Chang, R. Hershow, H. Minkoff, E. Rodriquez, C. Zorrilla, H. Hammill, and J. Regan, Vaginal colonization or infection with Candida albicans in human immunodeficiency virus-infected women during pregnancy and during postpartum period. Clin. Inf. Dis., 24: 201-210, 1997.
  • A. Duerr, M.F. Sierra, J. Feldman, L.M. Clarke, I. Ehlich, and J. Dehovitz, Immune compromise and prevalence of Candida vulvovaginitis in human immunodeficiency virus-infected women. Obstet. Gynecol., 90: 252-256, 1997.
  • A. Spinillo, G. Michelone, C. Cavanna, L. Colonna, E. Capuzzo, and S. Nicola, Clinical and microbiological characteristics of symptomatic vulvovaginal candidiasis in HIV-seropositive women. Genitourin. Med., 70: 268-272, 1994.
  • M.H. White, Is vulvovaginal candidiasis an AIDS-related illness. Clin. Infect. Dis., 22(Suppl. 2): S124-S127, 1996.
  • R.A. Clark, S.A. Blakley, J. Rice, and W. Brandon, Predictors of HIV progression in women. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 9: 43-50, 1995.
  • P. Schuman, J.D. Sobel, S. Ohmit, K.H. Mayer, A. Rompalo, A. Duerr, D.K. Smith, D. Warren, and R.S. Klein, Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection. Clin. Infect. Dis., 27: 1161-1167, 1998.
  • J.L. Rhoads, D.C. Wright, R.R. Redfield, and D.S. Burke, Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA, 257: 3105-3107, 1987.
  • N. Imam, C.C. J. Carpenter, K.H. Mayer, A. Fisher, M. Stein, and S.B. Danforth, Hierarchical pattern of mucosal Candida infections in HIV-seropositive women. Amer. J. Med., 89: 142-146, 1990.
  • L.P. Samaranayake, Oral mycoses in HIV infection. Oral Surg. Oral Med. Oral Pathol., 73: 171-180, 1992.
  • R.L. Fidel, Jr., N.A. Wolf, J.L. Cutright, J.D. Sobel, and P. Schuman, Candidaspecific Thl/Th2 reactivity in HIV+ women with and without vulvovaginal candidiasis. (2000) (Submitted).
  • M.B. Parr and E.L. Parr, Antigen recognition in the female reproductive tract: I. Uptake of intraluminal protein tracers in the mouse vagina. J. Reprod. Immunol., 17: 101-114, 1990.
  • M.B. Parr, L. Kepple, and E.L. Parr, Antigen recognition in the female reproductive tract. II. Endocytosis of horseradish peroxidase by Langerhans cells in murine vaginal epithelium. Biol. Reprod., 45: 261-265, 1991.
  • S. Itohara, A.G. Farr, J.J. Lafaille, M. Bonneville, Y. Takagaki, W. Hass, and S. Tonegawa, Homing of a gamma/delta thymocyte subset with homogenous T-cell receptors to mucosal epithelia. Nature, 343: 754-757, 1990.
  • D. Nandi and J.P. Allison, Phenotypic analysis and gamma/delta T cell receptor repertoire of murine T cells associated with the vaginal epithelium. J. Immunol., 147: 1773-1778, 1991.
  • A.R. Ibraghimov, R.E. Sacco, M. Sandor, Z. lakoubov, and R.G. Lynch, Resident CD4+ aß T cells of the murine female genital tract: A phenotypically distinct T cell lineage that rapidly proliferates in response to systemic T cell activation stimuli. Int. Immunol., 7: 1763-1769, 1995.
  • F. Hladik, G. Lentz, E. Delpit, A. McElroy, and M.J. McElrath, Coexpression of CCR5 and IL-2 in human genital but not blood cells: Implications for the ontogeny of the CCR5 + Thl phenotype. J. Immunol., 163: 2306-2313, 1999.
  • G. Inghirami, B.Y. Zhu, L. Chess, and D.M. Knowles, Flow cytometric and immunohistochemical characterization of the gamma/delta T-lymphocyte population in normal human lymphoid tissue and peripheral blood. Amer. J. Pathol., 136: 357-367, 1990.
  • E. -L. Johansson, A. Rudin, L. Wassen, and J. Holmgren, Distribution of lymphocytes and adhesion molecules in human cervix and vagina. Immunology, 96: 272-277, 2000.
  • H.D. White, K.M. Crassi, A.L. Givan, J.E. Stern, J.L. Gonzalez, V.A. Memoli, W.R. Green, and C.R. Wira, CD3 + CDS + CTL activity within the human female reproductive tract: Influence of stage of the menstrual cycle and menopause. J. Immunol., 158: 3017-3027, 1997.
  • F.L. Wormley, Jr., M. Scott, W. Luo, M. Baker, J. Chaibon, and P.L. Fidel, Jr., Evidence for a unique expression of CD4 on murine CD4+ vaginal cells. Immunology, 2000: 300-308.
  • R.E. Bachelder, J. Bilancieri, W. Lin, and N.L. Letvin, A human recombinant Fab identifies a human immunodeficiency virus type-I induced conformational change in cell-surface-expressed CD4. J. Virol., 69: 5734-5742, 1995.
  • A.M. Michie, J.R. Carlyle, and J.C. Zuniga-Pflucker, Early intrathymic precursor cells acquire a CD4low phenotype. J. Immunol., 160: 1735-1741, 1998.
  • N. Lonberg, S.N. Gettner, E. Lacy, and D.R. Littman, Mouse brain CD4 transcripts encode only the COOH-terminal half of the protein. Mol. Cell. Biol. 8: 2224-2228, 1988.
  • B. Tourvieille, S.D. Gorman, E.H. Field, T. Hunkapiller, and J.R. Parnes, Isolation and sequence of L3T4 complementary DNA clones: Expression in T cells and brain. Science, 234: 610-614, 1986.
  • R. Haars, P. Conradt, I. Miltner, and H. Wagner, A novel form of CD4 (L3T4) mRNA in the murine fetal liver results in cell-surface expression of the L3T4 antigen. Scand. J. Immunol., 34: 253-258, 1991.
  • P.L. Fidel, Jr., F.L. Wormley, Jr., J. Chaibon, R.R. Cresson, and V. Lounev, Analysis of the CD4 protein on human vaginal CD4+ T cells. 2001, Am J Reprod. Immunol. 45: 200-204.
  • E. Rakasz, M. Hagen, M. Sandor, and R.G. Lynch, ?d cells of the murine vagina: T cell response in vivo in the absence of the expression of CD2 and CD28 molecules. Int. Immunol., 9: 161-167, 1997.
  • E. Rakasz, M. Sandor, M. Hagen, and R.G. Lynch, Activation features of intraepithelial ?d T-cells of the murine vagina. Immunology Letters, 54: 129-134, 1996.
  • M.T. Cantoma, D. Mook, and E. Balish, Resistance of congenitally immunodeficient gnotobiotic mice to vaginal candidiasis. Infect. Immun., 58: 3813-3815, 1990.
  • J. Jones-Carson, A. Vazquez-Torres, H.C. van der Heyde, T. Warner, R.D. Wagner, and E. Balish, ?/d T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nature Medicine, 6: 552-557, 1995.
  • [97a] F.L. Wormley, Jr., C. Steele, K. Wozniak, K. Fujihashi, J.R. McGhee, and P.L. Fidel, Jr. Resistance of TCR d-chain deficient mice to experimental Candida vaginitis. Infect. Immun. 69: 7162-7164, 2001.
  • P.L. Fidel, Jr., W. Luo, C. Steele, J. Chabain, M. Baker, and F.L. Wormley, Analysis of vaginal cell populations during experimental vaginal candidiasis. Infect. Immun., 67: 3135-3140, 1999.
  • T.K. Cain and R.G. Rank, Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect. Immun., 63(5): 1784-1789, 1995.
  • K.A. Kelly and R.G. Rank, Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis. Infect. Immun., 65: 5198-5208, 1997.
  • M.B. Parr and E.L. Parr, Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes. J. Virol., 72: 2677-2685, 1998.
  • M.B. Parr and E.L. Parr, Protective immunity against HSV-2 in the mouse vagina. J. Reprod. Immunol., 36: 77-92, 1997.
  • [102a] K.A. Kelly, H.L. Gray, J.C. Walker, R.G. Rank, F.L. Wormley, Jr., and P.L. Fidel, Jr. Chlamydia trachomatis infection does not enhance local cellular immunity against concurrent Candida vaginal infection. Infect. Immun., 69: 3451-3454, 2001.
  • M. Saavedra, B. Taylor, N.W. Lukacs, and P.L. Fidel, Jr., Local production of chemokines during experimental vaginal candidiasis. Infect. Immun., 67: 5820-5829, 1999.
  • B.N. Taylor, M. Saavedra, and P.L. Fidel, Jr., Local Thl/Th2 cytokine production during experimental vaginal candidiasis. Med. Mycol. 38: 419-431, 2000.
  • F. Sallusto, A. Lanzavecchia, and C.R. Mackay, Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today, 19: 568-574, 1998.
  • P.L. Fidel, Jr., K.A. Ginsburg, J.L. Cutright, N.A. Wolf, D. Leaman, K. Dunlap, and J.D. Sobel, Vaginal-associated immunity in women with recurrent vulvova- ginal candidiasis: Evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen. J. Infect. Dis., 176: 728-739, 1997.
  • P. Regulez, J.F. Garcia Fernandez, M.D. Moragues, J. Schneider, G. Quindos, and J. Ponton, Detection of anti-Candida albicans IgE antibodies in vaginal washes from patients with acute vulvovaginal candidiasis. Gynecol. Obstet. Invest., 37: 110-114, 1994.
  • S.S. Witkin, J. Jeremias, and W.J. Ledger, Vaginal eosinophils and IgE antibodies to Candida albicans in women with recurrent vaginitis. J. Med. Vet. Mycol., 27: 57-58, 1989.
  • S.S. Witkin, J. Jeremias, and W.J. Ledger, A localized vaginal allergic response in women with recurrent vaginitis. J. Allergy Clin. Immunol., 81: 412-416, 1988.
  • M.B. Parr and E.L. Parr, Langerhans cells and T lymphocyte subsets in the murine vagina and cervix. Biol. Reprod., 44: 491-498, 1991.
  • W.H. Kutteh, Z. Moldoveanu, and J. Mestecky, Mucosal immunity in the female reproductive tract: Correlation of immunoglobulins, cytokines and reproductive hormones in human cervical mucus around the time of ovulation. AIDS Res. Human Retro., 14: 51-55, 1998.
  • C.A. Black, F.M. Eyers, A. Russell, M.L. Dunkley, R.L. Clancy, and K. W Beagley, Acute neutropenia decreases inflammation associated with murine vaginal candidiasis but has no effect on the course of infection. Infect. Immun., 66: 1273-1275, 1998.
  • Y. Sonoda, N. Mukaida, J. Wang, M. Shimada-Hiratsuka, M. Naito, T. Kasahara, A. Harada, M. Inoue, and K. Matsushima, Physiologic regulation of postovulatory neutrophil migration into vagina in mice by a C-X-C chemokine. J. Immunol., 160: 6159-6165, 1998.
  • G. Arancia, A. Molinari, P. Crateri, A. Stringaro, C. Ramoni, M.L. Dupuis, M.J. Gomez, A. Torosantucci, and A. Cassone, Noninhibitory binding of human interleukin-2-activated natural killer cells to the germ tube forms of Candida albicans. Infect. Immun., 63: 280-288, 1995.
  • S.R. Hedges, W.W. Agace, and C. Svanborg, Epithelial cytokine responses and mucosal cytokine networks. Trends in Microbiol., 3: 266-270, 1995.
  • R.A. Fratti, M.A. Ghannoum, J.E. Edwards, Jr., and S.G. Filler, Gamma inter- feron protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis. Infect. Immun., 64: 4714-4718, 1996.
  • C. Steele, H. Ozenci, W. Luo, M. Scott, and P.L. Fidel, Jr., Growth inhibition of Candida albicans by vaginal cells from naive mice. J. Med. Mycol., 37: 251-260, 1999.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.